000 | 01554 a2200469 4500 | ||
---|---|---|---|
005 | 20250515021627.0 | ||
264 | 0 | _c20060502 | |
008 | 200605s 0 0 eng d | ||
022 | _a0001-6462 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKinov, Plamen | |
245 | 0 | 0 |
_aEffect of risedronate on bone metabolism after total hip arthroplasty: a prospective randomised study. _h[electronic resource] |
260 |
_bActa orthopaedica Belgica _cJan 2006 |
||
300 |
_a44-50 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAbsorptiometry, Photon |
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aArthroplasty, Replacement, Hip _xadverse effects |
650 | 0 | 4 |
_aBone Density _xphysiology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aEtidronic Acid _xanalogs & derivatives |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHip Prosthesis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aJoint Instability _xprevention & control |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aProsthesis Failure |
650 | 0 | 4 | _aReference Values |
650 | 0 | 4 | _aRisedronic Acid |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aStatistics, Nonparametric |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aTivchev, Peter | |
700 | 1 | _aDoukova, Paulette | |
700 | 1 | _aLeithner, Andreas | |
773 | 0 |
_tActa orthopaedica Belgica _gvol. 72 _gno. 1 _gp. 44-50 |
|
999 |
_c16178086 _d16178086 |